Location History:
- Watchung, NJ (US) (1976 - 1982)
- San Francisco, CA (US) (1983 - 2001)
Company Filing History:
Years Active: 1976-2001
Title: The Innovative Achievements of Ching C. Wang in the Field of Pharmaceutical Research
Introduction: Ching C. Wang, a notable inventor based in San Francisco, California, has made significant contributions to the field of pharmaceutical research. With a remarkable portfolio of 8 patents, her work has focused on innovative solutions for treating parasitic infections in mammals, showcasing her commitment to advancing medical science.
Latest Patents: Among her latest patents, Ching C. Wang developed the following groundbreaking inventions: 1) Substituted 4-phthalimidocarboxanilides as inhibitors of purine salvage phosphoribosyltransferases. This patent reveals the potential of certain heterocyclic derivatives in treating parasitic protozoa infections in mammals, particularly bovine trichomoniasis and giardiasis. 2) Heterocyclic derivatives as inhibitors of purine salvage, which further explores the use of these compounds to combat similar parasitic infections.
Career Highlights: Ching C. Wang has built a commendable career working with reputable organizations such as Merck & Company, Inc. and the University of California. Her affiliation with these prestigious institutions has allowed her to collaborate with leading experts and contribute to cutting-edge research in pharmacology and medicinal chemistry.
Collaborations: Throughout her career, Ching C. Wang has had the opportunity to work alongside esteemed colleagues, including Irwin D. Kuntz and Michael H. Fisher. These collaborations have been instrumental in advancing her research and enhancing the impact of her inventions on the scientific community.
Conclusion: Ching C. Wang stands out as a pioneering inventor in the realm of pharmaceutical innovations. Her focused research on treating parasitic infections through the development of novel heterocyclic derivatives showcases her dedication to improving health outcomes. As she continues her work, the scientific community eagerly anticipates the potential benefits her innovations will bring.